M. Robles

Genomic analysis of primary and secondary myelofibrosis redefines the prognostic impact of ASXL1 mutations: a FIM study.

P. Cony-Makhoul, V. Ugo, E. Lippert, 2021, Blood advances.

Allogeneic SCT for patients with high-risk peripheral T-cell lymphoma in first response

G. Marit, N. Milpied, R. Tabrizi, 2013, Bone Marrow Transplantation.

JAK2 V617F polycythemia vera and essential thrombocythemia: dynamic clinical features associated with long-term outcomes

V. Ugo, E. Lippert, L. Roy, 2022, Blood Cancer Journal.